Farwell MD - Search Results

1

A PET imaging agent for evaluating PARP-1 expression in ovarian cancer.

Makvandi M, Pantel A, Schwartz L, Schubert E, Xu K, Hsieh CJ, Hou C, Kim H, Weng CC, Winters H, Doot R, Farwell MD, Pryma DA, Greenberg RA, Mankoff DA, Simpkins F, Mach RH, Lin LL. Makvandi M, et al. Among authors: farwell md. J Clin Invest. 2018 May 1;128(5):2116-2126. doi: 10.1172/JCI97992. Epub 2018 Apr 16. J Clin Invest. 2018. PMID: 29509546 Free PMC article. Clinical Trial.

2

PET/CT imaging in cancer: current applications and future directions.

Farwell MD, Pryma DA, Mankoff DA. Farwell MD, et al. Cancer. 2014 Nov 15;120(22):3433-45. doi: 10.1002/cncr.28860. Epub 2014 Jun 19. Cancer. 2014. PMID: 24947987 Free article. Review.

3

How Imaging Can Impact Clinical Trial Design: Molecular Imaging as a Biomarker for Targeted Cancer Therapy.

Mankoff DA, Farwell MD, Clark AS, Pryma DA. Mankoff DA, et al. Among authors: farwell md. Cancer J. 2015 May-Jun;21(3):218-24. doi: 10.1097/PPO.0000000000000116. Cancer J. 2015. PMID: 26049702 Review.

4

How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.

Farwell MD, Clark AS, Mankoff DA. Farwell MD, et al. JAMA Oncol. 2015 Jul;1(4):421-2. doi: 10.1001/jamaoncol.2015.0667. JAMA Oncol. 2015. PMID: 26181243 No abstract available.

5

Development of Companion Diagnostics.

Mankoff DA, Edmonds CE, Farwell MD, Pryma DA. Mankoff DA, et al. Among authors: farwell md. Semin Nucl Med. 2016 Jan;46(1):47-56. doi: 10.1053/j.semnuclmed.2015.09.002. Semin Nucl Med. 2016. PMID: 26687857 Free PMC article. Review.

6

Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging.

Chen X, Yang Y, Berger I, Khalid U, Patel A, Cai J, Farwell MD, Langer C, Aggarwal C, Albelda SM, Katz SI. Chen X, et al. Among authors: farwell md. Oncotarget. 2017 Apr 11;8(15):24213-24223. doi: 10.18632/oncotarget.12085. Oncotarget. 2017. PMID: 27655645 Free PMC article.

7

Renal Metastasis From Primary Thyroid Cancer on 131I and MRI Imaging.

Patel DR, Kamat BH, Farwell MD. Patel DR, et al. Among authors: farwell md. Clin Nucl Med. 2017 Jan;42(1):70-72. doi: 10.1097/RLU.0000000000001453. Clin Nucl Med. 2017. PMID: 27846002

8

Making Molecular Imaging a Clinical Tool for Precision Oncology: A Review.

Mankoff DA, Farwell MD, Clark AS, Pryma DA. Mankoff DA, et al. Among authors: farwell md. JAMA Oncol. 2017 May 1;3(5):695-701. doi: 10.1001/jamaoncol.2016.5084. JAMA Oncol. 2017. PMID: 28033451 Review.

9

FDG-Avid Focal Liver Reaction From Proton Therapy in a Patient With Primary Esophageal Adenocarcinoma.

Ahmed HS, Pantel AR, Metz JM, Plastaras JP, Farwell MD. Ahmed HS, et al. Among authors: farwell md. Clin Nucl Med. 2018 May;43(5):e139-e141. doi: 10.1097/RLU.0000000000002035. Clin Nucl Med. 2018. PMID: 29561521 Free PMC article.

10

The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.

Andriole GL, Kostakoglu L, Chau A, Duan F, Mahmood U, Mankoff DA, Schuster DM, Siegel BA; LOCATE Study Group. Andriole GL, et al. J Urol. 2019 Feb;201(2):322-331. doi: 10.1016/j.juro.2018.08.050. J Urol. 2019. PMID: 30179618 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters